Literature DB >> 12660140

Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle.

Arlene N James1, James P Ryan, Henry P Parkman.   

Abstract

Botulinum toxin injection into the pylorus is reported to improve gastric emptying in gastroparesis. Classically, botulinum toxin inhibits ACh release from cholinergic nerves in skeletal muscle. The aim of this study was to determine the effects of botulinum toxin on pyloric smooth muscle. Guinea pig pyloric muscle strips were studied in vitro. Botulinum toxin type A was added; electric field stimulation (EFS) was performed every 30 min for 6 h. ACh (100 microM)-induced contractile responses were determined before and after 6 h. Botulinum toxin caused a concentration-dependent decrease of pyloric contractions to EFS. At a low concentration (2 U/ml), botulinum toxin decreased pyloric contractions to EFS by 43 +/- 9% without affecting ACh-induced contractions. At higher concentrations (10 U/ml), botulinum toxin decreased pyloric contraction to EFS by 75 +/- 7% and decreased ACh-induced contraction by 79 +/- 9%. In conclusion, botulinum toxin inhibits pyloric smooth muscle contractility. At a low concentration, botulinum toxin decreases EFS-induced contractile responses without affecting ACh-induced contractions suggesting inhibition of ACh release from cholinergic nerves. At higher concentrations, botulinum toxin directly inhibits smooth muscle contractility as evidenced by the decreased contractile response to ACh.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660140     DOI: 10.1152/ajpgi.00296.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  26 in total

Review 1.  The use of botulinum toxin for the treatment of gastrointestinal motility disorders.

Authors:  Frank Friedenberg; Satya Gollamudi; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

2.  Regional differences in neostigmine-induced contraction and relaxation of stomach from diabetic guinea pig.

Authors:  Joseph Cellini; Karyn DiNovo; Jessica Harlow; Kathy J LePard
Journal:  Auton Neurosci       Date:  2010-11-13       Impact factor: 3.145

3.  Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study.

Authors:  Mark Topazian; Michael Camilleri; Jose De La Mora-Levy; Felicity B Enders; Amy E Foxx-Orenstein; Michael J Levy; Vandana Nehra; Nicholas J Talley
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

4.  Botulinum Toxin A Improves Symptoms of Gastroparesis.

Authors:  Zachary Wilmer Reichenbach; Steven Stanek; Shyam Patel; Sara Jane Ward; Zubair Malik; Henry P Parkman; Ron Schey
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

Review 5.  Endoscopic treatment of gastroparesis.

Authors:  Thomas R McCarty; Tarun Rustagi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 6.  Endoscopic botox injections in therapy of refractory gastroparesis.

Authors:  Andrew Ukleja; Kanwarpreet Tandon; Kinchit Shah; Alicia Alvarez
Journal:  World J Gastrointest Endosc       Date:  2015-07-10

Review 7.  The Role of Endoscopic Intra-Gastric Botulinum Toxin-A for Obesity Treatment.

Authors:  Hadya Elshakh; Khalid El-Ejji; Shahrad Taheri
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

8.  Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.

Authors:  Leonel Rodriguez; Rachel Rosen; Michael Manfredi; Samuel Nurko
Journal:  Gastrointest Endosc       Date:  2012-02       Impact factor: 9.427

9.  Intragastric injection of botulinum toxin A for the treatment of obesity.

Authors:  Reinhard Mittermair; Christian Keller; John Geibel
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

10.  Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight.

Authors:  Mark Topazian; Michael Camilleri; Felicity T Enders; Jonathan E Clain; Ferga C Gleeson; Michael J Levy; Elizabeth Rajan; Vandana Nehra; Ross A Dierkhising; Maria L Collazo-Clavell; Nicholas J Talley; Matthew M Clark
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-09       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.